Skip to Content

Inogen replaces CEO 

Inogen replaces CEO 

GOLETA, Calif. - Inogen’s board of directors today, Nov. 13, appointed Kevin Smith as president and CEO effective immediately, succeeding Nabil Shabshab. 

Smith, who will also be a member of the board, brings more than 20 years of commercial leadership experience in the medical device industry, including respiratory care and DME businesses, and has a history of success in executing value-creating transformations across organizations. He most recently served as CEO at Sirtex Medical, a global manufacturer of interventional treatment solutions. 

“We believe we have tremendous opportunities to scale our business, drive operational efficiencies and accelerate our growth trajectory, and the board believes it is the right time for new leadership to improve performance and support Inogen’s next phase of its journey,” said Elizabeth Mora, chairwoman. “With deep global medical device experience and a strong track record of successful business transformations, we believe Kevin is the right leader to capitalize on Inogen’s potential. We look forward to benefitting from his expertise as we seek to advance our commercial strategy, win new customers, and drive sustainable, long-term value for our shareholders.” 

Smith also previously held positions at Sensium Healthcare, Teleflex, Hillrom Holdings and ZOLL Medical Corp. 

Inogen named Shabshab CEO in January 2021, succeeding Scott Wilkinson. 

The company recently posted revenue declines for two of its three business segments. 


To comment on this post, please log in to your account or set up an account now.